KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX, page-28

  1. 6,848 Posts.
    lightbulb Created with Sketch. 2536
    Sorry Stayso. Me bad. Just annoys me that NOX is running on all the positive sides of GK style and NRT is running on all the negatives of GK styles. For example GK is great over communicator but deadlines were not meet. NOX is glorying in the positive we are suffering for the negative. To me that is just not right. IMHO of course.

    It seems to be all focused on an individual and not the IP. Whereas we are putting out notices of substance, ie IND approval, a good solid AR, and now and expansion of the company and no credit is granted. Nox putts out a notice that basically repeats it self ie all is travelling to the time line and it is marked price sensitive....what the hell???? And the SP skyrockets.....on thin air.
    Yes a tinge of the green giant but I don't like un level playing fields. Market darling and market dogs are often the stuff of weaved narratives.
    Last edited by harvett: 01/11/16
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.